-
Uncategorized
Biosimilar Boom on Hold? FDA’s Plan Confronts Patent Office Resistance
The FDA's new plan to streamline approval for biosimilars by reducing clinical trial requirements is being counteracted by the U.S.…
Read More » -
Pharma News
AI Titans Enter the Lab: How Nvidia, Microsoft, and Google are Reshaping Pharma R&D
Harnessing their multi-trillion-dollar valuations and immense computing power, AI giants Nvidia, Microsoft, and Google are making critical, strategic moves to…
Read More » -
AI
Eli Lilly and NVIDIA Forge Alliance to Build AI Drug Discovery Supercomputer
Eli Lilly and NVIDIA have partnered to build the most powerful AI-powered supercomputer in the pharmaceutical industry, creating an "AI…
Read More » -
Pharma News
FDA Navigates Shutdown: Core Functions Remain, But New Applications Halt
The FDA has successfully retained 86% of its staff and is using carryover funds to continue reviewing already-submitted drug and…
Read More » -
Pharma News
New FDA Ad Regulations Stir Controversy, Experts Say ‘Loophole’ Is a Misnomer
The FDA is cracking down on direct-to-consumer drug ads, claiming to close a "loophole" that allows companies to avoid fully…
Read More » -
AI
How AI Will Shape the Future of Drug Discovery
An AI revolution is reshaping the future of drug discovery by accelerating the process and enabling a new era of…
Read More » -
Pharma News
A New Wave of Biopharma Layoffs
The biopharma industry is experiencing a new wave of layoffs as companies grapple with a challenging economic landscape. Job cuts…
Read More » -
Pharma News
FDA Launches Program to Boost Domestic Drug Production Amidst Tariff Threats
Both the Trump administration and the FDA are pushing to move drug manufacturing to the United States. President Trump's plan…
Read More » -
AI
AI in Biopharma: Navigating the “Massive Transition” in Drugmaking Leadership
The artificial intelligence (AI) revolution is causing a fascinating tension in biopharma, as groundbreaking technology clashes with traditional drugmaking methods.…
Read More » -
AI
Pharma’s Struggle to Connect in the Age of Virtual Care
The pharmaceutical industry is struggling to keep pace with rapid changes in healthcare, particularly in how it connects with patients…
Read More »